ADA Scientific Sessions 2025 Abstract·13 JunThe High Prevalence of Metabolic Dysfunction–Associated Steatohepatitis (MASH) in People with T2D Support the Need for Screening to Prevent Future CirrhosisStudy in peoplePopulationsPaper